Table 1.
Pre-treatment | Post-treatment | Percent decrease | |
---|---|---|---|
White blood cells (per μL) | |||
WBC (×103) | 6.41 (±1.85) | 0.78 (±0.41) | 88% |
NE (×103) | 1.33 (±0.54) | 0.07 (±0.09) | 94% |
LY (103) | 5.02 (±1.78) | 0.63 (±0.28) | 88% |
MO (×103) | 0.29 (±0.16) | 0.06 (±0.03) | 80% |
Red blood cells (per μL) | |||
RBC (×106) | 9.31 (±1.08) | 8.75 (±0.61) | 6% |
HCT% | 53.10 (±8.07) | 52.40 (±3.54) | 1% |
PLT (×103) | 798.72 (±228.55) | 643.00 (±149.88) | 19% |
White blood cells (WBC), neutrophils (NE), lymphocytes (LY), monocytes (MO), red blood cells (RBC), hematocrit (HTC) and platelets (PLT).